During the past decade, National Kidney and Transplant Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Kidney and Transplant Institute" #1 sponsor was "Fresenius Kabi" with 1 trials, followed by "GenVivo, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Light Sciences Oncology" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Kidney and Transplant Institute" #1 collaborator was "Actoverco" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "National Kidney and Transplant Institute" are "Caloric Deficit" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Chronic Renal Anemia" (1 trials), "DNA Virus Infections" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "National Kidney and Transplant Institute" in a lesser frequency.

Most popular intervention types in "National Kidney and Transplant Institute" are "Drug" (5 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Cyclophosphamide 750 mg/m^2" (1 trials), "Darbepoetin Alfa" (1 trials), "Doxorubicin 50 mg/m^2" (1 trials) and "Epoetin Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Kidney and Transplant Institute" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Kidney and Transplant Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National Kidney and Transplant Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Kidney and Transplant Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".